REGISTER NOW

https://www.surveymonkey.com/r/KNFVC8N

This newly updated comprehensive course incorporates all six units outlined in FDA blueprint for safe opioid prescribing and provides necessary context for safe opioid prescribing by discussing biopsychosocial aspects of pain, the newest clinical guidelines on the treatment of chronic pain, and state policies about prescribing opioids.
 

The intended audience is all prescribers of ER/LA opioids which includes: pain specialists, primary care physicians, physician assistants, nurse practitioners, advanced practice nurses, dentists, addiction medicine physicians, psychiatrists and other physicians and clinicians.

Learn More

Learning Objectives

• Describe how to accurately assess patients with pain for consideration of an opioid trial.
• Discuss the establishment of realistic goals for pain management and restoration of function.
• Explain how to initiate opioid treatment (IR and ER/LA) safely and judiciously, maximizing efficacy while minimizing risks.
• Describe how to monitor and re-evaluate treatment continuously; discontinue safely when appropriate.
• Discuss how to counsel patients and caregivers about use, misuse, abuse, diversion, and overdose.
• List three ways to educate patients about safe storage and disposal of opioids.
• Demonstrate working knowledge and ability to access general and specific information about opioids, especially those used in your practice.

Opioid Prescribing Resources

ACCME Accreditation Statement:
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation:
ASAM designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

UCLA Integrated Substance Abuse Programs (ISAP) is approved by the American Psychological Association to sponsor continuing education for psychologists. UCLA ISAP maintains responsibility for this program and its content.

The training course meets the qualifications for the provision of two and one half (2.5) continuing education credits/ contact hours (CEs/CEHs). UCLA Integrated Substance Abuse Programs (ISAP) is approved by the American Psychological Association to sponsor continuing education for psychologists. UCLA ISAP maintains responsibility for this program and its content. UCLA ISAP is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for LMFTs, LCSWs, LPCCs, and/or LEPs (Provider #64812). UCLA ISAP maintains responsibility for this program/course and its content. Course meets the qualifications for two and one half (2.5) hours of continuing education credit for LMFTs, LCSWs, LPCCS, and LEPs as required by the California Board of Behavioral Sciences. UCLA ISAP is also an approved provider of continuing education for RADTs I/ II, CADCs-CASs, CADCs I/II, CADCs-CSs, and LAADCs (CCAPP, #2N-00-445-1119), CATCs (ACCBC/ CAADE, # CP40 872 C 0822), and CAODCs (CADTP, #151). Provider approved by the California Board of Registered Nursing, Provider #15455, for 2.5 contact hours.

CE credit will be awarded at the conclusion of the training. Partial credit will not be available for those participants who arrive late or leave early.

Instructions for Filing a Grievance Concerning UCLA ISAP’s Continuing Education Program: Please contact Dr. Thomas E. Freese, CE Program Administrator, in writing (UCLA ISAP, 11075 Santa Monica Boulevard, Suite 200, Los Angeles, CA 90025) or by phone (310-267-5397).